C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 498/08 (2006.01) A61K 31/12 (2006.01) A61K 31/40 (2006.01) A61K 38/06 (2006.01) A61K 38/07 (2006.01) C07D 498/18 (2006.01) C07K 5/08 (2006.01) C07K 5/10 (2006.01) C07K 5/12 (2006.01)
Patent
CA 2667031
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
L'invention concerne des composés macrocycliques représentés par la formule (I) qui conviennent comme inhibiteurs de la protéase NS3 du virus de l'hépatite C (VHC), leur synthèse et leur utilisation pour traiter ou prévenir des infections par le VHC.
Butcher John W.
Di Francesco Maria Emilia
Ferrara Marco
Gilbert Kevin F.
Harper Steven
Gowling Lafleur Henderson Llp
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.a.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Hcv ns3 protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hcv ns3 protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv ns3 protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1388732